(Q35144032)

6 August 2017

1 reference

title

Non-viral gene transfer therapy for cystic fibrosis (English)

1 reference

6 August 2017

0 references

Assem G Ziady

1

1 reference

6 August 2017

Pamela B Davis

series ordinal

2

1 reference

6 August 2017

Michael W Konstan

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Expert Opinion on Biological Therapy

6 August 2017

1 reference

6 August 2017

3

1 reference

6 August 2017

3

1 reference

6 August 2017

449-458

1 reference

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

6 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Gene therapy death prompts review of adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

A phage integrase directs efficient site-specific integration in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Development of non-viral vectors for systemic gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Sequence requirements for nuclear location of simian virus 40 large-T antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Five Percent of Normal Cystic Fibrosis Transmembrane Conductance Regulator mRNA Ameliorates the Severity of Pulmonary Disease in Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Sequences within the coding regions of clotting factor VIII and CFTR block transcriptional elongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Functional evidence of CFTR gene transfer in nasal epithelium of cystic fibrosis mice in vivo following luminal application of DNA complexes targeted to the serpin-enzyme complex receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

CFTR gene transfer reduces the binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Secreted and transmembrane mucins inhibit gene transfer with AAV4 more efficiently than AAV5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Size-dependent DNA mobility in cytoplasm and nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Intraluminal water increases expression of plasmid DNA in rat lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Cationic liposomes for direct gene transfer in therapy of cancer and other diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Role of intracellular cationic liposome-DNA complex dissociation in transfection mediated by cationic lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Poly(ethylenimine) and its role in gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Chain length of the polylysine in receptor-targeted gene transfer complexes affects duration of reporter gene expression both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Studies on artifical antigens. I. Antigenicity of DNP-polylysine and DNP copolymer of lysine and glutamic acid in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Galactosylated histone-mediated gene transfer and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Ligand substitution of receptor targeted DNA complexes affects gene transfer into hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Sugar-mediated uptake of glycosylated polylysines and gene transfer into normal and cystic fibrosis airway epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Gene therapy of cystic fibrosis (CF) airways: a review emphasizing targeting with lactose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Nuclear translocation of lactosylated poly-L-lysine/cDNA complex in cystic fibrosis airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

The polymeric immunoglobulin receptor: structure and synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Side-effects of a systemic injection of linear polyethylenimine-DNA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Evaluation of polyplexes as gene transfer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Effects of linear polyethylenimine and polyethylenimine/DNA on lung function after airway instillation to rat lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.3.449

21 January 2018

Identifiers

DOI

10.1517/14712598.3.3.449

1 reference

6 August 2017

1 reference